Ventus is pursuing a powerful new way to target innate immunity to treat diseases of high unmet medical need.

  • We are a biotech company developing small‑molecule therapeutics that target key innate immune pathways to treat autoimmune and auto‑inflammatory diseases.
  • We have assembled world leaders and advanced capabilities for structure-based drug development to translate structural immunology into a pipeline of novel medicines.